ENvue

ENvue Medical, Inc. (NASDAQ: FEED), formerly known as NanoVibronix, Inc., is a commercial-stage medical technology company specializing in intelligent, non-invasive solutions for enteral care and acoustic-based therapeutic technologies. The company's flagship product is the FDA 510(k)-cleared ENvue Navigation Platform, an electromagnetic navigation system that provides real-time, bedside guidance for the precise placement of enteral feeding tubes. Additionally, ENvue Medical develops and commercializes wearable therapeutic devices, including PainShield and UroShield, which utilize proprietary low-intensity surface acoustic wave (SAW) technology to treat pain and prevent catheter-associated urinary tract infections. Headquartered in Tyler, Texas, with research and development based in Tel Aviv, Israel, the company is focused on expanding its enteral-feeding ecosystem and scaling its clinical adoption across U.S. hospital networks.